| Migraine attack frequency | In the citrate trial, attack frequency fell by 41.6% from baseline versus 15.8% with placebo. A separate trial of a different magnesium preparation did not detect an advantage. | 1/4 Very lowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 22 separate trialsProphylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study ↗ | 81 adults with migraine | - Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study ↗
- Magnesium in the prophylaxis of migraine-a double-blind, placebo-controlled study ↗
|
|---|
| Systolic blood pressure | Across the mixed groups, systolic blood pressure was 2.81 mmHg lower on average. No convincing difference was found in participants with normal baseline blood pressure. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: The limited conclusion does not warrant a separate downgrade. There was no further downgrade in confidence on this basis. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesMagnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | 2,709 adults in 38 RCTs with varying baseline blood pressure | - Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| Diastolic blood pressure | Across the mixed groups, diastolic blood pressure was 2.05 mmHg lower on average. No convincing difference was found in participants with normal baseline blood pressure. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: The limited conclusion does not warrant a separate downgrade. There was no further downgrade in confidence on this basis. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesMagnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | 2,709 adults in 38 RCTs with varying baseline blood pressure | - Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| Weekly frequency of leg cramps | No convincing difference was found in the number of leg cramps per week. Cramps at any time of day were counted. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedSecondary prevention of leg cramps using compression stockings or magnesium supplements: a three-arm randomized clinical trial ↗ | Adults aged 50–85 with leg cramps at least twice a week. Cramps at any time of day were counted. | - Secondary prevention of leg cramps using compression stockings or magnesium supplements: a three-arm randomized clinical trial ↗
|
|---|
| Reduction in cramp frequency by at least half | In a small study of pregnant women with leg cramps, a reduction in cramp frequency by at least half was more common. Evidence from other studies is mixed, so this result should be interpreted cautiously. | 1/4 Very lowRisk of bias: Some participants dropped out. The counts and percentages in the abstract need to be reconciled with the full text. Consistency across studies: According to the Cochrane review, trials of cramps during pregnancy produced conflicting results. Applicability to the stated group: The evidence applies directly only to pregnant women with the stated symptoms. There was no further downgrade in confidence on this basis. Precision of the estimate: One small study. The precision of the estimate and the safety data are limited. Potential publication bias: No specific publication bias was identified. There was no further downgrade in confidence on this basis. | 22 publications describedOral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial ↗ | 86 healthy pregnant women at 14–34 weeks of gestation with leg cramps at least twice a week. 80 completed the study. | - Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial ↗
- Interventions for leg cramps during pregnancy | Cochrane ↗
|
|---|
| Relief of chronic constipation | A response was observed in 32/47 versus 9/47. This is a laxative dose of a specific salt and differs from a typical nutritional dose of magnesium. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesThe effect of food, vitamin, or mineral supplements on chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials ↗ | 94 adults with chronic constipation in two RCTs | - The effect of food, vitamin, or mineral supplements on chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials ↗
|
|---|
| Fasting glucose | Across the mixed groups, fasting glucose was 3.60 mg/dL lower on average. The outcome was fasting glucose. Diabetes incidence was not assessed by this measure. | 1/4 Very lowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The reported pooled estimate explicitly includes different groups and magnesium salts. It cannot predict the effect in a healthy person or the effect of any single salt. There was no further downgrade in confidence on this basis. Precision of the estimate: Small average effects and pooled intervals across different groups do not provide a reliable basis for expecting a meaningful change in any one person. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesComprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Various groups of adults, including people with diabetes and prediabetes | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
|
|---|
| Glycated hemoglobin (HbA1c) | The average change in HbA1c in the review was small. A separate one-year trial in adults with type 2 diabetes found no convincing difference versus placebo. | 1/4 Very lowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The reported pooled estimate explicitly includes different groups and magnesium salts. It cannot predict the effect in a healthy person or the effect of any single salt. There was no further downgrade in confidence on this basis. Precision of the estimate: Small average effects and pooled intervals across different groups do not provide a reliable basis for expecting a meaningful change in any one person. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 21 review and 1 separate trialComprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Various groups of adults, including people with diabetes | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
- The effect of oral magnesium supplementation on glycemic control and metabolic parameters in type 2 diabetes mellitus: a double-blind randomized controlled trial ↗
|
|---|
| Fasting insulin | The review found no convincing overall change in fasting insulin. HOMA-IR is a separate measure. | 1/4 Very lowRisk of bias: Concerns include reporting, dropout, disclosure of treatment assignment, or selection. Consistency across studies: Results vary across studies by participant group, intervention, or outcome, or individual studies contradict one another. Applicability to the stated group: The evidence applies directly only to the stated group, formulation, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: The number of participants is small, the interval is wide, or comparative data are incomplete. Potential publication bias: No specific indication of publication bias was identified. There was no further downgrade in confidence on this basis. | 11 review of studiesComprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Adults with varying baseline health status and cardiometabolic risk | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
|
|---|
| Depressive symptoms (final HDRS score) | Final HDRS scores were 10.7 versus 10.4, with no convincing difference at the endpoint. The scores reflect endpoint values and cannot be read as a difference in change from baseline. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesEffects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response ↗ | 37 adults with depression taking fluoxetine, with 32 assessed at week eight | - Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response ↗
|
|---|
| Perceived stress (PSS) | The PSS comparison showed no convincing difference. Participants were not selected based on stress. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The stated question specifically concerns people with poor sleep and their PSS stress or PHQ anxiety scores. No general conclusion about treating anxiety follows from the scope of that question. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedMagnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial ↗ | Adults with poor sleep | - Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial ↗
|
|---|
| Anxiety (PHQ-4 subscale) | No difference was detected on the PHQ-4 anxiety subscale. Small effects cannot be ruled out. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The stated question specifically concerns people with poor sleep and their PSS stress or PHQ anxiety scores. No general conclusion about treating anxiety follows from the scope of that question. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedMagnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial ↗ | Adults with poor sleep | - Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial ↗
|
|---|
| Stress (DASS-42) | Mean scores on day 28 were 21.8 versus 21.6, with no convincing overall benefit. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedShort-Term Magnesium Therapy Alleviates Moderate Stress in Patients with Fibromyalgia: A Randomized Double-Blind Clinical Trial ↗ | Patients with fibromyalgia and stress | - Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients with Fibromyalgia: A Randomized Double-Blind Clinical Trial ↗
|
|---|
| NIH composite cognitive test score | Mean scores increased by 8.40 versus 5.60 points, a difference in change of +2.80 points. The link with daily functioning was not established. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedThe effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial ↗ | 100 adults aged 18–45 who were dissatisfied with their sleep | - The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial ↗
|
|---|
| Soreness after downhill running | A small crossover study reported reduced soreness. Evidence on tolerability and functional recovery is limited. | 1/4 Very lowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the specified group. The group of interest is the nine male runners with low magnesium intake, and the outcome is soreness. There was no further downgrade in certainty for this domain. Precision of the estimate. The crossover study had only nine participants and provided no reliable interval for the paired effect. The direction and magnitude of the effect are therefore very uncertain. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedOne week of magnesium supplementation lowers IL-6, muscle soreness and increases post-exercise blood glucose in response to downhill running ↗ | Nine male runners were prescribed a diet containing less than 260 mg of magnesium per day during the study | - One week of magnesium supplementation lowers IL-6, muscle soreness and increases post-exercise blood glucose in response to downhill running ↗
|
|---|
| Maximal oxygen uptake (VO₂max) | Maximal oxygen uptake was lower with magnesium (41.3 versus 44.4 mL/kg/min, p=0.005). | 1/4 Very lowRisk of bias. Of the 22 participants enrolled, only 15 completed the oxygen uptake test and 13 completed the sprint. Substantial missing outcome data and analysis limited to completers raise serious concerns about bias. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedShort-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical Trial ↗ | 15 young adult completers who were training | - Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical Trial ↗
|
|---|
| Mean sprint power | Mean power during the 30-second cycling sprint was lower with magnesium (415 versus 439 W, p=0.03). | 1/4 Very lowRisk of bias. Of the 22 participants enrolled, only 15 completed the oxygen uptake test and 13 completed the sprint. Substantial missing outcome data and analysis limited to completers raise serious concerns about bias. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedShort-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical Trial ↗ | 13 of the 22 participants enrolled completed the sprint test | - Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical Trial ↗
|
|---|
| Combined bone mineral content across three hip sites | Over one year, combined bone mineral content across three hip sites increased by about 1.05 g with magnesium and 0.97 g with placebo. The result was borderline (p=0.0534 in the table). | 2/4 LowRisk of bias: Concerns include reporting, dropout, disclosure of treatment assignment, or selection. Consistency across studies. This outcome comes from a single double-blind, one-year trial, so consistency across studies could not be assessed. There was no further downgrade in certainty for this domain. Applicability to the stated group: The evidence applies directly only to the stated group, formulation, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: The number of participants is small, the interval is wide, or comparative data are incomplete. Potential publication bias: No specific indication of publication bias was identified. There was no further downgrade in confidence on this basis. | 11 publication describedA randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls ↗ | 50 girls aged 8–14 with low magnesium intake, of whom 44 completed the study | - A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls ↗
|
|---|
| Total hip bone mineral content | Over one year, total hip bone mineral content increased by about 1.33 g with magnesium and 1.29 g with placebo. No convincing difference between groups was found (p=0.577). | 2/4 LowRisk of bias: Concerns include reporting, dropout, disclosure of treatment assignment, or selection. Consistency across studies. This outcome comes from a single double-blind, one-year trial, so consistency across studies could not be assessed. There was no further downgrade in certainty for this domain. Applicability to the stated group: The evidence applies directly only to the stated group, formulation, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: The number of participants is small, the interval is wide, or comparative data are incomplete. Potential publication bias: No specific indication of publication bias was identified. There was no further downgrade in confidence on this basis. | 11 publication describedA randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls ↗ | 50 girls aged 8–14 with low magnesium intake, of whom 44 completed the study | - A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls ↗
|
|---|
| Quality of life measured with the SF-36 questionnaire | The overall SF-36 quality-of-life score was higher with magnesium than with placebo in this group of women with PCOS (p<0.001). | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedThe effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗ | 64 women with PCOS from a fertility clinic were randomized, and 54 completed the study | - The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗
|
|---|
| Acne | No convincing difference between groups was found. Small effects cannot be ruled out. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedThe effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗ | 64 women with PCOS from a fertility clinic were randomized, and 54 completed the study | - The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗
|
|---|
| Alopecia | No convincing difference between groups was found. Small effects cannot be ruled out. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedThe effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗ | 64 women with PCOS from a fertility clinic were randomized, and 54 completed the study | - The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗
|
|---|
| Abnormal uterine bleeding | No convincing difference between groups was found. Small effects cannot be ruled out. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedThe effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗ | 64 women with PCOS from a fertility clinic were randomized, and 54 completed the study | - The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial ↗
|
|---|
| Restless legs symptoms (IRLS) | Mean scores were 16.08 and 24.24. The published p-value applies to the comparison across all three groups. The adjusted pairwise effect and adult-only results were not established. | 1/4 Very lowRisk of bias. Unblinded researchers assessed subjective outcomes, and the handling of missing data and the pairwise comparison were insufficiently clear. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the specified group. The stated group includes people aged 15–50 taking the supplement alongside pramipexole. There is no separate estimate for adults alone. There was no further downgrade in certainty for this domain. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedTherapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial ↗ | 75 people aged 15–50 with restless legs syndrome who were taking pramipexole | - Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial ↗
|
|---|
| Short-term pain on a 0–100 scale | Across two trials, the mean difference was −0.55 points on a 0–100 pain scale (95% CI −8.32 to 7.21). No convincing reduction in pain was found. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 publication describedKetamine and other NMDA receptor antagonists for chronic pain ↗ | 118 adults with various types of chronic noncancer pain across two randomized controlled trials | - Ketamine and other NMDA receptor antagonists for chronic pain ↗
|
|---|
| Kidney stone recurrence | No convincing reduction in recurrence was established. The interval is compatible with both benefit and harm. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 22 publications described (1 review)Results. In: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies: Systematic Review ↗ | Patients with recurrent calcium oxalate stones | - Results. In: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies: Systematic Review ↗
- Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not ↗
|
|---|
| Kidney stone recurrence | The second dose also showed no clear benefit. It was evaluated in the same trial. | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 22 publications described (1 review)Results. In: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies: Systematic Review ↗ | The same population in the same trial | - Results. In: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies: Systematic Review ↗
- Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not ↗
|
|---|
| Total cholesterol | No convincing difference in total cholesterol was found across the mixed populations. The interval is compatible with both a decrease and an increase. | 2/4 LowRisk of bias. Most randomized controlled trials in the review had a low risk of bias, and no serious risk was identified for total cholesterol specifically. The problematic LDL/HDL data cells in the Sobhani study were outside the total cholesterol analysis. There was no further downgrade in certainty for this domain. Consistency across studies. Results varied substantially (I² = 65.7%). The exact source of the variation was not established. Applicability to the specified group. The outcome is total cholesterol pooled across different magnesium salts and patient populations. This outcome cannot establish whether clinical events are prevented. There was no further downgrade in certainty for this domain. Precision of the estimate. The interval from −5.65 to +2.35 mg/dL is compatible with both a decrease and an increase. No claim of equivalence is made. Possible publication bias. The review found insufficient grounds for a separate downgrade for this outcome. Unpublished results cannot be ruled out. There was no further downgrade in certainty for this domain. | 22 publications described (2 reviews)Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Various adult populations in the meta-analysis (34 estimates), including healthy adults and people with cardiometabolic diseases | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
- The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials ↗
|
|---|
| Triglycerides | In the 2026 review, triglycerides were lower by an average of 9.24 mg/dL (95% CI −16.87 to −1.61), but trial results varied substantially. The 2025 review found no convincing difference. | 2/4 LowRisk of bias. No serious risk was identified for this outcome specifically. The problematic LDL/HDL data cells in the Sobhani study were outside the triglyceride analysis. Most randomized controlled trials in the review had a low risk of bias. There was no further downgrade in certainty for this domain. Consistency across studies. Results varied substantially (I² = 76%). The exact source of the variation was not established. Applicability to the specified group. The outcome is a pooled estimate for triglycerides. It does not guarantee a result for any individual salt or the prevention of clinical events. There was no further downgrade in certainty for this domain. Precision of the estimate. The pooled interval from −16.87 to −1.61 supports a limited conclusion of a small average change. Differences across studies were accounted for separately in the consistency assessment. There was no further downgrade in certainty for this domain. Possible publication bias. The authors reported possible asymmetry or small-study bias for this outcome. | 22 publications described (2 reviews)Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Various adult populations in the meta-analysis (41 estimates), including healthy adults and people with cardiometabolic diseases | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
- The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials ↗
|
|---|
| Altitude sickness during rapid ascent | Altitude sickness symptoms were absent in 20% of participants taking magnesium and 16.1% taking placebo. No convincing benefit was found. Loose stools were more common with magnesium (38.2% versus 11.8%). | 2/4 LowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the stated group: The conclusion is limited to the stated group, dose, and outcome. There was no further downgrade in confidence on this basis. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 21 trial and 1 reviewMagnesium for the prevention and treatment of acute mountain sickness ↗ | 70 adults undergoing rapid ascent were randomized, and 61 were included in the efficacy analysis | - Magnesium for the prevention and treatment of acute mountain sickness ↗
- Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs ↗
|
|---|
| Menstrual pain | The authors reported reduced pain. The publications describe a similar protocol but list different salts, so these data cannot establish the effect of a specific form. | 1/4 Very lowRisk of bias. The way the small trial was reported and the conflicting salt names in the primary publications make it difficult to attribute the result to a specific product. The exact effect size is unreliable. Consistency across studies: No serious unexplained heterogeneity was identified for this outcome. There was no further downgrade in confidence on this basis. Applicability to the specified group. The outcome of interest is menstrual pain. Findings from another condition do not apply to this outcome. There was no further downgrade in certainty for this domain. Precision of the estimate: A small sample and a wide or unreported interval leave substantial uncertainty. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 22 publications with a similar protocolEffectiveness of Magnesium on Menstrual Symptoms Among Dysmenorrheal College Students: A Randomized Controlled Trial ↗ | 60 female students with moderate or severe primary menstrual pain | - Effectiveness of Magnesium on Menstrual Symptoms Among Dysmenorrheal College Students: A Randomized Controlled Trial ↗
- The Effect of Magnesium Sulfate on Pain Intensity and Menstrual Blood Loss in Students With Primary Dysmenorrhea: A Randomized Controlled Trial ↗
|
|---|
| Body weight | Body weight was lower by an average of 0.70 kg (95% CI −1.30 to −0.09). The estimate is sensitive to individual studies and applies to mixed populations. | 1/4 Very lowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The reported pooled estimate explicitly includes different groups and magnesium salts. It cannot predict the effect in a healthy person or the effect of any single salt. There was no further downgrade in confidence on this basis. Precision of the estimate: Small average effects and pooled intervals across different groups do not provide a reliable basis for expecting a meaningful change in any one person. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesComprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Adults across a mix of clinical and other populations | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
|
|---|
| Body fat percentage | No convincing difference was found. The mean change relative to control was −0.02 percentage points (95% CI −0.46 to 0.43). | 1/4 Very lowRisk of bias: Participant attrition, incomplete original study plans, or limited assessment of risk of bias in individual trials. Consistency across studies: High heterogeneity or inconsistency among individual controlled trials. Applicability to the stated group: The reported pooled estimate explicitly includes different groups and magnesium salts. It cannot predict the effect in a healthy person or the effect of any single salt. There was no further downgrade in confidence on this basis. Precision of the estimate: Small average effects and pooled intervals across different groups do not provide a reliable basis for expecting a meaningful change in any one person. Potential publication bias: No specific grounds for a separate downgrade were identified. Unpublished data may exist. There was no further downgrade in confidence on this basis. | 11 review of studiesComprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗ | Adults in mixed populations | - Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis ↗
|
|---|